Inventor · disambiguated record
Lakshminarayana Vogeti
Also filed as: VOGETI LAKSHMINARAYANA
23 granted patents·5 pending applications·435 citations·filing 2002–2024
95Inventor score
Top patents by PatentIndex Score
28 records- 0197US11590134B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Feb 28, 2023·19 cites·20 claims
- 0297US11530206B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 20, 2022·20 cites·37 claims
- 0397US11518758B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 6, 2022·16 cites·20 claims
- 0497US9309224B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 12, 2016·60 cites·40 claims
- 0597US9187474B2Raf inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted Nov 17, 2015·60 cites·19 claims
- 0696US9181223B22-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 10, 2015·62 cites·29 claims
- 0796US9133183B2Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Sep 15, 2015·60 cites·32 claims
- 0895US9382228B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 5, 2016·60 cites·43 claims
- 0995US9334267B2RAF inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted May 10, 2016·60 cites·17 claims
- 1091US11559515B2Indole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2020·Granted Jan 24, 2023·2 cites·19 claims
- 1187US10849883B2Benzopyrazole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2017·Granted Dec 1, 2020·3 cites·21 claims
- 1283US10562850B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2016·Granted Feb 18, 2020·2 cites·23 claims
- 1380US11066360B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jul 20, 2021·1 cites·20 claims
- 1480US2025084073A1Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1577US10759759B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2017·Granted Sep 1, 2020·1 cites·30 claims
- 1676US12485109B2Pyrrolo 12.3-dipyrimidine compounds and analogues thereofBIOCRYST PHARM INC·Filed 2023·Granted Dec 2, 2025·0 cites·7 claims
- 1776US2025250235A1Raf kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1874US12377097B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Aug 5, 2025·0 cites·14 claims
- 1973US12071432B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Aug 27, 2024·0 cites·28 claims
- 2072US6916801B27-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitorsALAMX LLC·Filed 2002·Granted Jul 12, 2005·9 cites·26 claims
- 2171US11807605B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Nov 7, 2023·0 cites·35 claims
- 2270US12319655B2RAF kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Jun 3, 2025·0 cites·31 claims
- 2369US12479833B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Nov 25, 2025·0 cites·30 claims
- 2468US11618731B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Apr 4, 2023·0 cites·13 claims
- 2561US2023357179A1Raf kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 2660US2024150368A1Ulk inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2751US7488724B27-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitorsUNIV SOUTHERN METHODIST·Filed 2005·Granted Feb 10, 2009·0 cites·13 claims
- 2849US2016046619A1Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lakshminarayana Vogeti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →